Related Experiment Video
Updated: Mar 6, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Menin and PRMT5 suppress GLP1 receptor transcript and PKA-mediated phosphorylation of FOXO1 and CREB
Abdul Bari Muhammad1,2, Bowen Xing3, Chengyang Liu4
1Abramson Family Cancer Research Institute, Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract:
Menin is a scaffold protein that interacts with several epigenetic mediators to regulate gene transcription, and suppresses pancreatic β-cell proliferation. Tamoxifen-inducible deletion of multiple endocrine neoplasia type 1 (MEN1) gene, which encodes the protein menin, increases β-cell mass in multiple murine models of diabetes and ameliorates diabetes. Glucagon-like-peptide-1 (GLP1) is another key physiological modulator of β-cell mass and glucose homeostasis. However, it is not clearly understood whether menin crosstalks with GLP1 signaling. Here, we show that menin and protein arginine methyltransferase 5 (PRMT5) suppress GLP1 receptor (GLP1R) transcript levels. Notably, a GLP1R agonist induces phosphorylation of forkhead box protein O1 (FOXO1) at S253, and the phosphorylation is mediated by PKA. Interestingly, menin suppresses GLP1-induced and PKA-mediated phosphorylation of both FOXO1 and cAMP response element binding protein (CREB), likely through a protein arginine methyltransferase. Menin-mediated suppression of FOXO1 and CREB phosphorylation increases FOXO1 levels and suppresses CREB target genes, respectively. A small-molecule menin inhibitor reverses menin-mediated suppression of both FOXO1 and CREB phosphorylation. In addition, ex vivo treatment of both mouse and human pancreatic islets with a menin inhibitor increases levels of proliferation marker Ki67. In conclusion, our results suggest that menin and PRMT5 suppress GLP1R transcript levels and PKA-mediated phosphorylation of FOXO1 and CREB, and a menin inhibitor may reverse this suppression to induce β-cell proliferation.
Insights
Menin and PRMT5 suppress GLP1R transcript levels and key signaling pathways. A menin inhibitor reverses this suppression, potentially promoting pancreatic beta-cell proliferation for diabetes treatment.
Area of Science:
- Endocrinology
- Molecular Biology
- Diabetes Research
Background:
- Menin (encoded by MEN1) is a scaffold protein regulating gene transcription and suppressing pancreatic beta-cell proliferation.
- Glucagon-like-peptide-1 (GLP1) influences beta-cell mass and glucose homeostasis, but its interaction with menin is unclear.
- Menin's role in diabetes pathogenesis and its potential modulation for therapeutic benefit warrant investigation.
Purpose of the Study:
- To investigate the crosstalk between menin and GLP1 signaling in pancreatic beta-cells.
- To determine if menin influences GLP1 receptor (GLP1R) expression and downstream signaling pathways.
- To evaluate the therapeutic potential of menin inhibition in promoting beta-cell proliferation.
Main Methods:
- Assessed menin and PRMT5 effects on GLP1R transcript levels.
- Investigated GLP1-induced phosphorylation of FOXO1 and CREB, and menin's role in this process.
- Utilized a small-molecule menin inhibitor to reverse menin-mediated suppression.
- Examined the impact of menin inhibition on beta-cell proliferation marker Ki67 in pancreatic islets.
Main Results:
- Menin and PRMT5 were found to suppress GLP1R transcript levels.
- Menin inhibits GLP1-induced and PKA-mediated phosphorylation of FOXO1 and CREB.
- Menin inhibition reversed suppression of FOXO1 and CREB phosphorylation, increasing FOXO1 levels and affecting CREB target genes.
- Ex vivo treatment with a menin inhibitor increased Ki67 levels in mouse and human pancreatic islets.
Conclusions:
- Menin and PRMT5 suppress GLP1R expression and key signaling pathways (FOXO1, CREB phosphorylation) involved in beta-cell function.
- A menin inhibitor can reverse menin-mediated suppression, suggesting a therapeutic strategy to induce beta-cell proliferation.
- Targeting menin offers a potential approach for managing diabetes by enhancing beta-cell mass.
More Related Videos
08:34Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
10:04A Filtration-based Method of Preparing High-quality Nuclei from Cross-linked Skeletal Muscle for Chromatin Immunoprecipitation
Published on: July 6, 2017
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
GPCRs Regulate Adenylyl Cylase Activity
Cell Specific Gene Expression
Amplifying Signals via Enzymatic Cascade
Master Transcription Regulators